Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2642)
All Articles published online
|
Aug 21, 2005 (publication date) through May 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li X, Meng Y, Yang XS, Mi LF, Cai SX. ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-β1, PDGF-BB, NF-κB and MMP-2,9. World J Gastroenterol 2005; 11(31): 4807-4811 [PMID: 16097048 DOI: 10.3748/wjg.v11.i31.4807] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i31/4807.htm |
| Number | Citing Articles |
| 1 |
Ibrahim Koral Onal, Bulent Altun, Eda Demir Onal, Alper Kırkpantur, Serife Gul Oz, Cetin Turgan. Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment. European Journal of Internal Medicine 2009; 20(4): 369 doi: 10.1016/j.ejim.2008.10.003
|
| 2 |
Eva Efsen, Torben Særmark, Alastair Hansen, Eywin Bruun, Jørn Brynskov. Ramiprilate Inhibits Functional Matrix Metalloproteinase Activity in Crohn’s Disease Fistulas. Basic & Clinical Pharmacology & Toxicology 2011; 109(3): 208 doi: 10.1111/j.1742-7843.2011.00713.x
|
| 3 |
John S Lubel, Chandana B Herath, Louise M Burrell, Peter W Angus. Liver disease and the renin–angiotensin system: Recent discoveries and clinical implications. Journal of Gastroenterology and Hepatology 2008; 23(9): 1327 doi: 10.1111/j.1440-1746.2008.05461.x
|
| 4 |
Xiao Zhao, Jennifer Yin Yee Kwan, Kenneth Yip, Peter P. Liu, Fei-Fei Liu. Targeting metabolic dysregulation for fibrosis therapy. Nature Reviews Drug Discovery 2020; 19(1): 57 doi: 10.1038/s41573-019-0040-5
|
| 5 |
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, Simonetta Bandiera, Naoto Fujiwara, Hussein El Saghire, Shijia Zhu, Tongqi Qian, Fahmida Akter Rasha, Fabio Del Zompo, Stephen C. Barrett, Eugénie Schaeffer, Marine A. Oudot, Clara Ponsolles, Sarah C. Durand, Sarani Ghoshal, Gunisha Arora, Fabio Giannone, Raymond T. Chung, Nevena Slovic, Nicolaas Van Renne, Emanuele Felli, Patrick Pessaux, Joachim Lupberger, Nathalie Pochet, Catherine Schuster, Kenneth K. Tanabe, Yujin Hoshida, Bryan C. Fuchs, Thomas F. Baumert. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation. JCI Insight 2022; 7(13) doi: 10.1172/jci.insight.159254
|
| 6 |
O. Guillaud, K.C. Gurram, M. Puglia, L. Lilly, O. Adeyi, E.L. Renner, N. Selzner. Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation. Transplantation Proceedings 2013; 45(6): 2331 doi: 10.1016/j.transproceed.2013.01.067
|
| 7 |
Hala M. Raslan, Khalda S. Amr, Yasser A. Elhosary, Wafaa M. Ezzat, Nour A. Abdullah, Hassan E. El-Batae. Possible role of angiotensin-converting enzyme polymorphism on progression of hepatic fibrosis in chronic hepatitis C virus infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 2011; 105(7): 396 doi: 10.1016/j.trstmh.2011.03.005
|
| 8 |
Stefanie Hemmann, Jürgen Graf, Martin Roderfeld, Elke Roeb. Expression of MMPs and TIMPs in liver fibrosis – a systematic review with special emphasis on anti-fibrotic strategies. Journal of Hepatology 2007; 46(5): 955 doi: 10.1016/j.jhep.2007.02.003
|
| 9 |
Lindsey J. Reese, Diane S. Tider, Alicia C. Stivala, Dawn A. Fishbein. Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection. AIDS Research and Treatment 2012; 2012: 1 doi: 10.1155/2012/978790
|
| 10 |
Mao‐liang Huang, Xu Li, Ying Meng, Bing Xiao, Qiang Ma, Song‐song Ying, Ping‐sheng Wu, Zhen‐shu Zhang. Upregulation of angiotensin‐converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clinical and Experimental Pharmacology and Physiology 2010; 37(1) doi: 10.1111/j.1440-1681.2009.05302.x
|
| 11 |
Peihong Dong, Fujun Yu, Xufei Fan, Zhuo Lin, Yongping Chen, Ji Li. Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells. Molecular and Cellular Biochemistry 2010; 344(1-2): 195 doi: 10.1007/s11010-010-0542-2
|
| 12 |
Montserrat Moreno, Ramon Bataller. Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis. Clinics in Liver Disease 2008; 12(4): 825 doi: 10.1016/j.cld.2008.07.013
|
| 13 |
Anureet K. Shah, Sushma Yadav, Hoda Yeganehjoo. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; 25: 3 doi: 10.1007/978-3-031-23621-1_1
|
| 14 |
T D Gilmore, M Herscovitch. Inhibitors of NF-κB signaling: 785 and counting. Oncogene 2006; 25(51): 6887 doi: 10.1038/sj.onc.1209982
|
| 15 |
Jamshid Karimi, Adel Mohammadalipour, Nasrin Sheikh, Iraj Khodadadi, Mohammad Hashemnia, Farjam Goudarzi, Vahid Khanjarsim, Ghasem Solgi, Mehrdad Hajilooi, Majid Bahabadi, Nejat Kheiripour, Keshvad Hedayatyanfard. Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Drug and Chemical Toxicology 2020; 43(5): 468 doi: 10.1080/01480545.2018.1504960
|
| 16 |
Sandor Koszegi, Agnes Molnar, Lilla Lenart, Judit Hodrea, Dora Bianka Balogh, Tamas Lakat, Edgar Szkibinszkij, Adam Hosszu, Nadja Sparding, Federica Genovese, Laszlo Wagner, Adam Vannay, Attila J Szabo, Andrea Fekete. RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition. The Journal of Physiology 2019; 597(1): 193 doi: 10.1113/JP277002
|